The latest update is out from Eiger Biopharmaceuticals (EIGR).
Christine A. Murray has announced her resignation from the Board of Directors of Eiger BioPharmaceuticals, effective March 15, 2024. Her decision to step down is not due to any disagreements with the company’s operations, policies, or practices.
For a thorough assessment of EIGR stock, go to TipRanks’ Stock Analysis page.